Zone 1 by is a Otc medication manufactured, distributed, or labeled by Dermal Source, Inc., HTO Nevada, Inc. (dba Kirkman). Drug facts, warnings, and ingredients follow.
Do not use if pregnant or breast-feeding.
Do not use if you have seizures or liver disease.
Do not use if you have a known allergy or sensitivity to any 
component of this product. If sensitivity occurs, discontinue 
use, immediately cleanse skin and seek medical attention. If 
condition worsens or if symptoms persist for more than seven 
days or clear up and occur again, discontinue use and consult 
a doctor. Do not use in large quantities, particularly over raw 
surfaces or blistered areas. Avoid contact with eyes. In case of 
contact with eyes, rinse immediately with copious amounts of 
eyewash and seek treatment by a medical professional. If 
accidentally swallowed, get medical attention immediately.
Directions: Sensitivity test advised prior to use.
Apply a moderately thick layer of cream to intact skin. Discontinue use if 
sensitivity occurs. Wait for numbness to develop. For thinner skin (eye 
area) wait 10-15 minutes. For thicker skin, best results are obtained 
after 1 hour of application. Cleanse area thoroughly before procedure. 
MAXIMUM
Zone 1
TOPICAL ANALGESIC
7 pH
1/2 oz.
4% Lidocaine Cream
for use before a 
pain sensitive procedure
Distributed by: DERMAL SOURCE
Portland, OR 97232
www.dermalsource.com
1-866-568-3223
NDC: 80069-014-01

| ZONE 1 		
					
 lidocaine hcl cream  | 
||||||||||||||||||||||||||||
  | 
||||||||||||||||||||||||||||
  | 
||||||||||||||||||||||||||||
  | 
||||||||||||||||||||||||||||
  | 
||||||||||||||||||||||||||||
  | 
||||||||||||||||||||||||||||
| Labeler - Dermal Source, Inc. (183535629) | 
| Establishment | |||
| Name | Address | ID/FEI | Business Operations | 
|---|---|---|---|
| HTO Nevada, Inc. (dba Kirkman) | 117115846 | manufacture(80069-014) | |
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() ZONE 1  78411782  3005130 Live/Registered  | 
        DERMAL SOURCE  2004-05-01  |